Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...

Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...

Dear Doctors: Can you please do a column about familial hypercholesterolemia? It is my diagnosis, and I would like you to explain it. My LDL is over 500. It is my understanding that there are ...

Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can cause dangerously high cholesterol and early heart disease ...

FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to reduce plasma LDL-C levels.

High cholesterol, or hypercholesterolemia, affects nearly 1 in 3 American adults—yet it often goes undetected until a serious event like a heart attack or stroke occurs. It's one of the major ...

Familial hypercholesterolemia (FH) is a genetic disorder and the most common primary lipid disorder of childhood, affecting 1 in 250-350 children. FH causes severely high low-density lipoprotein ...

YolTech Therapeutics has received the US Food and Drug Administration (FDA) approval for its investigational new drug (IND) application for YOLT-101 to treat heterozygous familial hypercholesterolemia ...

Approval expands indication of JUXTAPID® to include children 2 years of age and older with HoFH. This announcement was made ...